The charts on this page feature a breakdown of the total annual pay for the top executives at UNITEDHEALTH GROUP INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. UNITEDHEALTH GROUP INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. UNITEDHEALTH GROUP INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Stephen J. Hemsley
President and Chief Executive Officer
Total Cash $6,240,000 Equity $7,000,028 Other $154,804 Total Compensation $13,394,832
David S. Wichmann
Executive Vice President and Chief Financial Officer
Total Cash $3,626,892 Equity $7,000,070 Other $84,212 Total Compensation $10,711,174
George L. Mikan III
Former Executive Vice President and Chief Financial Officer
Total Cash $2,107,692 Equity $7,000,070 Other $83,012 Total Compensation $9,190,774
Anthony Welters
Executive Vice President
Total Cash $3,258,831 Equity $4,500,060 Other $112,118 Total Compensation $7,871,009
Larry C. Renfro
Executive Vice President and Chief Executive Officer, Optum
Total Cash $3,567,292 Equity $7,000,070 Other $35,825 Total Compensation $10,603,187
Gail K. Boudreaux
Executive Vice President and Chief Executive Officer, UnitedHealthcare
Total Cash $3,831,892 Equity $7,000,070 Other $93,353 Total Compensation $10,925,315
For its 2021 fiscal year, UNITEDHEALTH GROUP INC, listed the following board members on its annual proxy statement to the SEC.
F. William McNabb, III Total Cash $347,669
Gail R. Wilensky, Ph.D. Total Cash $365,978
Glenn M. Renwick Total Cash $248,500
John H. Noseworthy, M.D. Total Cash $340,787
Michele J. Hooper Total Cash $366,094
Paul R. Garcia Total Cash $15,000
Richard T. Burke Total Cash $433,827
Stephen J. Hemsley Total Cash $574,628
Timothy P. Flynn Total Cash $374,350
Valerie C. Montgomery Rice, M.D. Total Cash $363,973

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.